157 related articles for article (PubMed ID: 25316601)
21. A Novel SYNJ1 Mutation in a Tunisian Family with Juvenile Parkinson's Disease Associated with Epilepsy.
Ben Romdhan S; Sakka S; Farhat N; Triki S; Dammak M; Mhiri C
J Mol Neurosci; 2018 Oct; 66(2):273-278. PubMed ID: 30187305
[TBL] [Abstract][Full Text] [Related]
22. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T; Tolosa E; Ferrer I
Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
[TBL] [Abstract][Full Text] [Related]
23. Clonazepam improves the symptoms of two siblings with novel variants in the SYNJ1 gene.
Hong D; Cong L; Zhong S; He Y; Xin L; Gao X; Zhang J
Parkinsonism Relat Disord; 2019 May; 62():221-225. PubMed ID: 30473187
[TBL] [Abstract][Full Text] [Related]
24. Following the leader: fibrillization of alpha-synuclein and tau.
Frasier M; Wolozin B
Exp Neurol; 2004 Jun; 187(2):235-9. PubMed ID: 15144849
[No Abstract] [Full Text] [Related]
25. Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.
Belrose JC; Masoudi R; Michalski B; Fahnestock M
Neurobiol Aging; 2014 Apr; 35(4):926-33. PubMed ID: 24112788
[TBL] [Abstract][Full Text] [Related]
26. A peculiar constellation of tau pathology defines a subset of dementia in the elderly.
Kovacs GG; Molnár K; László L; Ströbel T; Botond G; Hönigschnabl S; Reiner-Concin A; Palkovits M; Fischer P; Budka H
Acta Neuropathol; 2011 Aug; 122(2):205-22. PubMed ID: 21437732
[TBL] [Abstract][Full Text] [Related]
27. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
28. Transgenic zebrafish as a novel animal model to study tauopathies and other neurodegenerative disorders in vivo.
Paquet D; Schmid B; Haass C
Neurodegener Dis; 2010; 7(1-3):99-102. PubMed ID: 20173336
[TBL] [Abstract][Full Text] [Related]
29. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
[TBL] [Abstract][Full Text] [Related]
30. Interface between tauopathies and synucleinopathies: a tale of two proteins.
Galpern WR; Lang AE
Ann Neurol; 2006 Mar; 59(3):449-58. PubMed ID: 16489609
[TBL] [Abstract][Full Text] [Related]
31. Infantile tauopathies: Hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma.
Sarnat HB; Flores-Sarnat L
Brain Dev; 2015 Jun; 37(6):553-62. PubMed ID: 25451314
[TBL] [Abstract][Full Text] [Related]
32. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):658-64. PubMed ID: 12410387
[TBL] [Abstract][Full Text] [Related]
33. Early-onset familial lewy body dementia with extensive tauopathy: a clinical, genetic, and neuropathological study.
Clarimón J; Molina-Porcel L; Gómez-Isla T; Blesa R; Guardia-Laguarta C; González-Neira A; Estorch M; Ma Grau J; Barraquer L; Roig C; Ferrer I; Lleó A
J Neuropathol Exp Neurol; 2009 Jan; 68(1):73-82. PubMed ID: 19104444
[TBL] [Abstract][Full Text] [Related]
34. The neuropathological spectrum of neurodegenerative tauopathies.
Tolnay M; Probst A
IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
[TBL] [Abstract][Full Text] [Related]
35. Tau protein and neurodegeneration.
Goedert M
Semin Cell Dev Biol; 2004 Feb; 15(1):45-9. PubMed ID: 15036206
[TBL] [Abstract][Full Text] [Related]
36. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs.
Burns JM; Galvin JE; Roe CM; Morris JC; McKeel DW
Neurology; 2005 Apr; 64(8):1397-403. PubMed ID: 15851730
[TBL] [Abstract][Full Text] [Related]
37. Mutational analysis of SYNJ1 gene (PARK20) in Parkinson's disease in a Taiwanese population.
Chen KH; Wu RM; Lin HI; Tai CH; Lin CH
Neurobiol Aging; 2015 Oct; 36(10):2905.e7-8. PubMed ID: 26149920
[TBL] [Abstract][Full Text] [Related]
38. Is intractable epilepsy a tauopathy?
Xi ZQ; Wang XF; Shu XF; Chen GJ; Xiao F; Sun JJ; Zhu X
Med Hypotheses; 2011 Jun; 76(6):897-900. PubMed ID: 21440375
[TBL] [Abstract][Full Text] [Related]
39. Tau oligomers as potential targets for early diagnosis of tauopathy.
Sahara N; Ren Y; Ward S; Binder LI; Suhara T; Higuchi M
J Alzheimers Dis; 2014; 40 Suppl 1():S91-6. PubMed ID: 24595194
[TBL] [Abstract][Full Text] [Related]
40. Patterns of hippocampal tau pathology differentiate neurodegenerative dementias.
Milenkovic I; Petrov T; Kovacs GG
Dement Geriatr Cogn Disord; 2014; 38(5-6):375-88. PubMed ID: 25195847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
